Uridine Binding Motifs of Human Concentrative Nucleoside Transporters 1 and 3 Produced in Saccharomyces cerevisiae

Molecular Pharmacology

Volumn 64, Issue 6, 2003, Pages 1512-1520

  Zhang, Jing ^a,b   Visser, Frank ^a,b   Vickers, Mark F ^a,b   Lang, Thack ^a,b   Robins, Morris J ^c   Nielsen, Lars P C ^c   Nowak, Ireneusz ^c   Baldwin, Stephen A ^d   Young, James D ^a   Cass, Carol E ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c Brigham Young University   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; NUCLEOSIDE TRANSPORTER; NUCLEOSIDE TRANSPORTER 1; NUCLEOSIDE TRANSPORTER 2; NUCLEOSIDE TRANSPORTER 3; UNCLASSIFIED DRUG; URIDINE;

ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; DRUG TRANSPORT; HUMAN; HYDROGEN BOND; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE TRANSPORT PROTEINS; NUCLEOSIDE TRANSPORT PROTEINS; PROTEIN BINDING; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; URIDINE;

EID: 10744233849     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.6.1512     Document Type: Article

References (40)

1. Baldwin SA, Mackey JR, Cass CE, and Young JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5:216-224.
2. Bender DM, Hennings DD, and Williams RM (2000) A synthesis of 5′-amino-3′,5′-dideoxyuridine. Synthesis 3:399-402.
3. Brunelli JP and Pall ML (1993) A series of yeast/Escherichia coli 1 expression vectors designed for directional cloning of cDNAs and cre/lox-mediated plasmid excision. Yeast 9:1309-1318.
4. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45-53.
5. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AML, Ritzel MWL, et al. (1999) Nucleoside transporters of mammalian cells, in Membrane Transporters as Drug Targets (Amidon GL and Sadee W eds) pp 313-352, Kluwer Academic Publishers, Norwell, MA.
6. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. Codington JF, Fecher R, and Fox JJ (1960) Pyrimidine nucleosides. VII. Reactions of 2′,3′,5′-trimesyloxyuridine. J Am Chem Soc 82:2794-2803.
8. de Koning HP and Jarvis SM (2001) Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. Acta Trop 80:245-250.
9. Graham KA, Leithoff J, Coe IR, Mowles D, Mackey JR, Young JD, and Cass CE (2000) Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids 19:415-434.
10. +-nucleoside cotransporter rCNT1. J Biol Chem 276:27981-27988.
11. Hampton A and Nichol AW (1966) Nucleotides. V. Purine ribonucleoside 2′, 3′-cyclic carbonates. Preparation and use for the synthesis of 5′-monosubstituted nucleosides. Biochemistry 5:2076-2082.
12. Horwitz JP, Tomson AJ, Urbanski JA, and Chua J (1962) Nucleosides. I. 5′-Amino-5′-deoxyuridine and 5′-amino-5′-deoxythymidine. J Org Chem 27:3045-3048.
13. Hovinen J (1997) Selective N3- and 5′-O-alkylation of 2′,3′-O-isopropylideneuridine with methyl iodide. Helv Chim Acta 80:851-855.
14. Huang QQ, Yao SY, Ritzel MW, Paterson AR, Cass CE, and Young JD (1994) Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem 269:17757-17760.
15. Ito H, Fukuda Y, Murata K, and Kimura A (1983) Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153:163-168.
16. Lai Y, Bakken AH, and Unadkat JD (2002) Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies. J Biol Chem 277:37711-37717.
17. Latini S and Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-484.
18. + nucleoside cotransporters hCNT1 and hCNT2. J Biol Chem 274:24475-24484.
19. Lu X, Gong S, Monks A, Zaharevitz D, and Moscow JA (2002) Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity. J Exp Ther Oncol 2:200-212.
20. Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA, Crawford CR, and Cass CE (1998) Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 58:4349-4357.
21. Mackey JR, Yao SY, Smith KM, Karpinski E, Baldwin SA, Cass CE, and Young JD (1999) Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J Natl Cancer Inst 91:1876-1881.
22. Matray TJ and Gryaznov SM (1999) Synthesis and properties of RNA analogs-oligoribonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res 27:3976-3985.
23. +-nucleoside transporters in the human intestine. Am J Physiol 280:G475-G481.
24. +-nucleoside transporters. Cancer Chemother Pharmacol 46:394-402.
25. Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, and Coe IR (2001) Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem Biophys Res Commun 280:951-959.
26. Rhie S-Y and Pfleiderer W (1994) Nucleosides. LVI. Synthesis and chemical modifications of 3′-deoxypyrimidine nucleosides. Nucleosides Nucleotides 13:1425-1452.
27. +-nucleoside cotransporter (hCNT1). Am J Physiol 272:C707-C714.
28. +/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol 15:203-211.
29. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914-2927.
30. Robins MJ, Hansske F, Wnuk SF, and Kanai T (1991) Nucleic acid related compounds. 66. Improved syntheses of 5′-chloro-5′-deoxy- and 5′-S-aryl(or alkyl)-5′-thionucleosides. Can J Chem 69:1468-1474.
31. Robins MJ, Naik SR, and Lee ASK (1974) Nucleic acid related compounds. 12. The facile and high-yield stannous chloride catalyzed monomethylation of the cis-glycol system of nucleosides by diazomethane. J Org Chem 39:1891-1899.
32. Verheyden JPH, Wagner D, and Moffatt JG (1971) Synthesis of some pyrimidine 2′-amino-2′-deoxynucleosides. J Org Chem 36:250-254.
33. Vickers MF, Kumar R, Visser F, Zhang J, Charania J, Rabom RT, Baldwin SA, Young JD, and Cass CE (2002) Comparison of the interaction of uridine, cytidine and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochem Cell Biol 80:639-644.
34. Vickers MF, Mani RS, Sundaram M, Hogue DL, Young JD, Baldwin SA, and Cass CE (1999) Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem J 339:21-32.
35. Vickers MF, Yao SY, Baldwin SA, Young JD, and Cass CE (2000) Nucleoside transporter proteins of Saccharomyces cerevisiae. Demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J Biol Chem 275:25931-25938.
36. Vickers MF, Young JD, Baldwin SA, Ellison MJ, and Cass CE (2001) Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Mol Membr Biol 18:73-79.
37. Visser F, Vickers MF, Ng AM, Baldwin SA, Young JD, and Cass CE (2002) Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 277:395-401.
38. Wallace LJ, Candlish D, and De Koning HP (2002) Different substrate recognition motifs of human and trypanosome nucleobase transporters. Selective uptake of purine antimetabolites. J Biol Chem 277:26149-26156.
39. Wang Y, Hogenkamp HPC, Long RA, Revankar GR, and Robins RK (1977) A convenient synthesis of 5′-deoxyribonucleosides. Carbohydr Res 59:449-457.
40. Yung NC and Fox JJ (1961) Nucleosides. X. Anhydronucleosides and related compounds derived from 2′, 5′-di-O-trityluridine. J Am Chem Soc 83:3060-3066.